Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
复制标题
DOI:
10.4049/jimmunol.1100686
复制
发表时间:
2011-07-15
期刊:
影响因子:
--
通讯作者:
Waller EK
中科院分区:
文献类型:
--
作者:
Li JM;Southerland L;Hossain MS;Giver CR;Wang Y;Darlak K;Harris W;Waschek J;Waller EK
Vasoactive intestinal peptide (VIP) induces regulatory dendritic cells (DC) in vitro that inhibit cellular immune responses. We tested the role of physiological levels of VIP on immune responses to murine cytomegalovirus (mCMV) using VIP-knockout (VIP-KO) mice and radiation chimeras engrafted with syngenic VIP-KO hematopoietic cells. VIP-KO mice and had less weight loss and better survival following mCMV infection compared with wild-type littermates (WT). MCMV-infected VIP-KO mice had lower viral loads, faster clearance of virus, with increased numbers of IFN-γ+ NK and NKT cells, and enhanced cytolytic activity of NK cells. Adaptive anti-viral cellular immunity was increased in mCMV-infected VIP-KO mice compared with WT mice, with more Th1/Tc1 polarized T-cells, fewer IL-10+ T-cells, and more mCMV-M45 epitope peptide-MHC class I-tetramer+ CD8+ T-cells (tetramer+ CD8 T-cells). MCMV-immune VIP-KO mice had enhanced ability to clear mCMV-peptide pulsed target cells in vivo. Enhanced anti-viral immunity was also seen in WT transplant recipients engrafted with VIP-KO hematopoietic cells, indicating that VIP synthesized by neuronal cells did not suppress immune responses. Following mCMV infection there was a marked up-regulation of MHC class II (MHC-II) and CD80 co-stimulatory molecule expression on DC from VIP-KO mice compared with DC from WT mice, while PD-1 and PD-L1 expression were up-regulated in activated CD8+ T-cells and DC, respectively, in WT mice but not in VIP-KO mice. Since the absence of VIP in immune cells increased innate and adaptive anti-viral immunity by altering co-stimulatory and co-inhibitory pathways, selective targeting of VIP-signaling represents an attractive therapeutic target to enhance anti-viral immunity.
登录
查看更多内容
影响因子:
30.5
作者:
Andrews, DM;Andoniou, CE;Degli-Esposti, MA
通讯作者:
Degli-Esposti, MA
影响因子:
5.3
作者:
Herrera JL;Gonzalez-Rey E;Fernandez-Montesinos R;Quintana FJ;Najmanovich R;Pozo D
通讯作者:
Pozo D
影响因子:
4.7
作者:
Girard, Beatrice A.;Lelievre, Vincent;May, Victor
通讯作者:
May, Victor
影响因子:
4.4
作者:
Gold, MC;Munks, MW;Fling, SP
通讯作者:
Fling, SP
DOI:
10.1073/pnas.0406035101
发表时间:
2004-09-21
影响因子:
11.1
作者:
Brockstedt, DG;Giedlin, MA;Dubensky, TW
通讯作者:
Dubensky, TW